Market Reports

Meeting the global demand for high quality pharmaceutical packaging

Meeting the global demand for high quality pharmaceutical packaging

Amidst a flurry of recent announcements at the recent DCAT Week in New York, Dr Kevin Robinson sat down with Dr Frank Heinricht, Chairman of the Management Board of SCHOTT AG, to discover how the company is addressing issues in the pharmaceutical value chain, from glass tubing to packaging and the application of artificial intelligence
Continuous manufacturing: making it real

Continuous manufacturing: making it real

Industry pioneers GEA, Siemens and Perceptive Engineering recently hosted the inaugural Reality of Continuous Pharmaceutical Manufacturing conference in Durham, UK, to examine the current status of going conti and present real-life applications to an international audience. Dr Kevin Robinson reports
Global serialisation: Russian track and trace readiness

Global serialisation: Russian track and trace readiness

Christoph Krähenbühl, Senior Director of Excellis Europe, explains the challenge that the new Russian traceability regulations present to the pharma industry and how all participants in the supply chain must properly prepare to ensure that they become compliant within this new environment
Backend, baffling and buzzing: blockchain

Backend, baffling and buzzing: blockchain

Marco Mohwinckel, healthcare executive and adviser, takes a closer look at the invisible backend technology that has been touted as a revolution
Digitalisation in specialty chemicals and pharmaceuticals

Digitalisation in specialty chemicals and pharmaceuticals

Paige Marie Morse, Industry Director, AspenTech talks to Dr Kevin Robinson about accelerating innovation and optimising the value chain with digital technologies
Supporting precision with precision

Supporting precision with precision

As biologics steadily grow in pipeline development and commercialisation, they inherently require precise and meticulous support to ensure effective delivery to the patient
The economic advantages of continuous flow chemistry

The economic advantages of continuous flow chemistry

Batch production has been the traditional workhorse of the pharmaceutical manufacturing sector. However, economic advantages are taking continuous flow out of the realm of a niche technology for high energy, hazardous reactions to become an essential part of the small molecule manufacturing toolkit
The modularisation of chemical API synthesis

The modularisation of chemical API synthesis

The modularisation of chemical synthesis pathways in pharmaceutical production can improve overall plant efficiency and reduce planning time. Glatt Ingenieurtechnik has optimised the active pharmaceutical ingredient (API) synthesis process and developed bespoke plant designs for several international customers
Rare diseases: understanding the patient journey

Rare diseases: understanding the patient journey

In the shadow of Rare Disease Day on 28 February 2019, Dr Kevin Robinson met with Zizi Imatorbhebhe, Senior Director of Strategic Development and Head of PAREXEL’s Rare Disease Center of Excellence (RDCE), to discuss the future of rare disease research
A new paradigm in vaccines and cancer treatments

A new paradigm in vaccines and cancer treatments

Specialist pharmaceutical company N4 Pharma is developing Nuvec, a unique non-viral adjuvant delivery system for vaccines and cancer treatments. This silica nanoparticle has the potential to help commercialise cancer immunotherapy drugs and improve the effectiveness of viral vaccines. Dr Kevin Robinson recently caught up with Nigel Theobald, CEO of N4 Pharma, to find out more
Fuelling pharma’s innovation engines

Fuelling pharma’s innovation engines

Wishing to assess the current state of Alcami’s target market, Dr Kevin Robinson recently sat down with President and CEO, Dr Stephan Kutzer, to discuss its health, innovation and future aspirations
Broad stripes, bright stars and a thriving pharmaceutical industry: part I

Broad stripes, bright stars and a thriving pharmaceutical industry: part I

According to one of Stephen Sondheim’s most well-known lyrics, “I like to be in America! OK by me in America!” But, given the geography, politics, population, regulation and funding that are unique to the United States, Dr Kevin Robinson looked west to the Land of the Free to find out how the pharmaceutical industry is faring amongst all the milk and honey
The hidden risk of contamination

The hidden risk of contamination

Pharmaceutical companies may be unwittingly putting production processes at risk of contamination by fitting pumps with mechanical seals that fail to comply with industry regulations, says John Smiddy, European Sales and Technical Support Director for AESSEAL
A revolutionary method of liquid flow measurement

A revolutionary method of liquid flow measurement

Pharmaceutical supplier opts for innovative hygienic flowmeter
Next-generation safety testing

Next-generation safety testing

In vitro genetic testing offers an ethical alternative to animal testing, which is also cheaper, faster and more reliable
Developments and the future of pharmaceutical packaging

Developments and the future of pharmaceutical packaging

With the global primary packaging market in the pharmaceutical sector expected to experience remarkable growth during the next few years, Dr Kevin Robinson asked a number of industry experts to comment on the hurdles, drivers and emerging trends that are influencing how drugs are formulated, packaged and delivered

Trending Articles

  1. You need to be a subscriber to read this article.
    Click here to find out more.
    How onco-HPAPI manufacturing is adapting to a new era The oncology landscape is undergoing a quiet but powerful shift. Pharmaceutical companies, once focused primarily on novel compounds, are now increasingly exploring repurposing opportunities with existing high-potency oncology APIs (onco-HPAPIs)
  2. The economic advantages of continuous flow chemistry Batch production has been the traditional workhorse of the pharmaceutical manufacturing sector. However, economic advantages are taking continuous flow out of the realm of a niche technology for high energy, hazardous reactions to become an essential part of the small molecule manufacturing toolkit
  3. Addressing glass particulates in injectable drug formulations Glass particles are a frequent contaminant risk when producing injectable drugs on high speed filling lines. Glassmaker Corning has studied the root causes and engineered a new glass product for use on existing equipment that significantly reduces that risk
  4. Using ddPCR to accurately quantify AAV viral titre and integrity Gene therapy is primed to become the next major development in medicine and bring relief to patients living with diseases ranging from haemophilia to Alzheimer’s disease, write Mark White, Associate Director of Biopharma Product Marketing, and Marwan Alsarraj, Biopharma Segment Manager, Bio-Rad
  5. Host cell protein analysis: strategies to improve sensitivity and reproducibility Given that the US FDA approved 25 new cellular and gene therapy products in 2022, gene-based vaccines and therapeutics have now entered the mainstream pharmaceutical industry. However, the rising interest in gene-based strategies puts pressure on manufacturers to demonstrate optimum efficacy and safety

Upcoming event

CPhI Milan

6–8 October 2026 | Exhibition | Fiera Milano, Italy See all